Description: Medtronic plc (NYSE:MDT) ranks among the best slow growth stocks to invest in. Truist Securities increased its price target for Medtronic plc (NYSE:MDT) to $110 from $103 on November 20, while maintaining a Hold rating on the company’s shares. The gain comes after Medtronic’s fiscal second-quarter results, which revealed revenue growth led by the company’s […]

Description: Medtronic has outperformed the Medical Devices industry over the past year, and analysts are cautiously optimistic about the stock’s prospects.

Description: During the recent China International Import Expo (CIIE), the reporter delivered on-camera coverage to offer an interpretive guide to the event.

Description: Medtronic reported strong second-quarter results and raised its revenue and earnings guidance for the coming quarters and fiscal years, with management highlighting a renewed focus on tuck-in acquisitions in higher-growth cardiology and neuroscience segments. The company’s emphasis on investments in near- or on-market technologies, alongside upward guidance revisions, signals confidence in ongoing innovation and execution across its core businesses. We’ll examine how this improved outlook...

Description: The Middle East & Africa home healthcare market is growing rapidly, driven by rising demand for home-based medical care. Key opportunities include expansion in the services segment, leveraging the market's CAGR of 8.1% from 2019 to 2024, and addressing competitive pressures to capture market share.Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Home Healthcare in Middle East & Africa" report has been added to ResearchAndMarkets.com's offering.Home Healthcare in Middle East & Africa industry profi

Description: Medtronic (MDT) gave investors something to talk about after reporting higher sales and profits compared to last year, and raising its outlook for both revenue and earnings. See our latest analysis for Medtronic. Medtronic’s upbeat outlook has added fuel to a rally that’s been building for much of this year, with the stock’s share price climbing nearly 31% year-to-date and posting a robust 11.6% 1-month gain. Strong quarterly results and plans for strategic acquisitions in high-growth therapy...

Description: Restore Medical Ltd., a privately held medical device company developing a novel transcatheter therapy for heart failure, today announced the appointment of Chris Cleary, former Senior Vice President of Corporate Development at Medtronic, as Chairman of its Board of Directors.

Description: The Pediatric Interventional Cardiology Market is poised for significant growth, projected to rise from USD 2.42 billion in 2024 to USD 4.34 billion by 2033, exhibiting a 6.68% CAGR. This expansion is driven by the increasing prevalence of congenital heart defects such as VSD, PDA, and ASD in children. The advent of advanced medical devices and the shift towards non-invasive treatments also contribute to market growth. The U.S. stands out as a key player due to rising infant cardiac abnormalitie

Description: Extending Medicare reimbursement for cardiac catheter ablation to settings outside the hospital is expected to boost procedure volumes and benefit Abbott, Boston Scientific, J&J and Medtronic.

Description: Medtronic stock jumped 2% on Monday as it broke out to a 52-week high and is showing signs of strong accumulation. Medtronic stock recently received an RS Rating upgrade from 67 to 82 making it a great stock to consider for a bullish option trade. A bull call spread involves buying a call and then selling a further out-of-the-money call.

Description: A report higher Q4 revenues and lifts its 2026 outlook, yet the stock slips as margins narrow across key business segments.

Description: Medtronic stock has recently seen its fair value price target raised to $109.82 per share, up from $101.13. This change reflects improved analyst sentiment. The upward revision, combined with a slightly lower discount rate, is largely attributed to the company's robust revenue growth projections and continued operational strength. Stay tuned to discover the key drivers behind these changes and how you can keep up with the evolving narrative around Medtronic’s outlook. Analyst Price Targets...

Description: Underscoring India's rising influence in global cardiovascular innovation, Meril Life Sciences presented the one-year outcomes from the pivotal LANDMARK Randomized Controlled Trial (RCT) during the Late-Breaking Trial sessions at PCR London Valves 2025, one of the world's most respected structural heart conferences. This milestone marks a significant moment for Indian MedTech, as the indigenous, balloon-expandable Myval THV series is directly compared with leading international transcatheter val

Description: The global defibrillator market is forecasted to expand significantly, increasing from US$ 13.74 billion in 2024 to US$ 25.80 billion by 2033, with a steady CAGR of 7.25%. Key drivers include the proliferation of public access defibrillators, expanded ambulance services, and a surge in cardiac ailments. Defibrillators like AEDs and manual devices remain crucial in enhancing survival rates during cardiac arrest emergencies. Top players such as Medtronic, Boston Scientific, and Philips are pivotal

Description: The global neonatal intensive care market is forecasted to grow from $3.68 billion in 2024 to $6.27 billion by 2033, at a CAGR of 6.10%. Neonatal Intensive Care (NIC) focuses on critically ill newborns, particularly premature or congenital-condition babies. The rise in medical technology boosts survival rates, increasing NICU demand. Key players like Masimo Corporation, 3M Company, Medtronic PLC, and others are advancing in this life-saving area. Recent innovations, sustainability efforts, and s

Description: The respiratory care devices market is projected to grow from $24.16 billion in 2024 to $49.19 billion by 2033, at a CAGR of 8.22%. The rise is fueled by increasing cases of respiratory diseases such as asthma, COPD, and sleep apnea. Key devices include nebulizers, inhalers, CPAP machines, and ventilators, crucial for therapy and patient monitoring. Top players like Medtronic, Philips, GE Healthcare, and others are driving innovation. Sustainability efforts are notable among companies like Baxte

Description: Intuitive Surgical's robotics surge and Medtronic's broad innovation push set the stage for a high-tech showdown in next-gen minimally invasive care.

Description: SUNNYVALE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [NASDAQ: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces the appointment of Farhan Shahab as Vice President of Quality. Mr. Shahab brings over 25 years of experience to BioCardia in similar executive roles. Mr. Shahab joins BioCardia from Welldoc (a digital health company focused on chronic disease management), where he served as Vice P

Description: The global Medical Precision Parts Market is projected to grow at a CAGR of 5.78% from 2024-2030. Driven by lab automation, precision fluidic components like micro-valves and pipetting heads advance personalized medicine. Advanced engineering boosts biocompatibility and anti-fouling, exemplified by Medtronic implants. CNC-machined parts lead with 28% market share, while metals, particularly titanium and stainless steel, drive demand in orthopedic implants. North America dominates due to advanced

Description: Medtronic is proving that it's a reliable company to invest in.

Description: Medtronic is nearing a crowning achievement.

Description: Robotic surgery is a hot field, with new entrants coming.

Description: We recently published 13 Stocks That Crossed Jim Cramer’s Radar. Medtronic plc (NYSE:MDT) is one of the stocks Jim Cramer discussed. Medtronic plc (NYSE:MDT) is a medical technology company that makes and sells devices for cardiovascular, neuroscience, and surgical applications. Cramer has discussed the firm on a handful of occasions in 2025. One such discussion […]

Description: Ever wondered if Medtronic could be a hidden gem in today’s market? Let’s break down what’s really going on with its stock value and what that might mean for potential investors like you. Medtronic’s share price has climbed 3.3% in the last week and is up a notable 23.8% year-to-date, suggesting either confidence in its long-term prospects or changing attitudes around risk in the healthcare sector. News has recently highlighted Medtronic’s focus on innovation, including partnerships and new...

Description: These companies have been raising their payouts for a combined 101 consecutive years.

Description: The global surgical stapling devices market, valued at $5.23 billion in 2023, is anticipated to grow to $8.32 billion by 2029, with a CAGR of approximately 8%. This growth is propelled by the rising demand for minimally invasive procedures and increased healthcare investments, especially in emerging nations. Market segmentation highlights the dominance of disposable and powered surgical stapling devices due to convenience and enhanced functionality. North America leads, driven by innovative tech

Description: Medtronic Spark Scholarship provides financial assistance and access to support services for students pursuing health tech and related degrees NORTHAMPTON, MA / ACCESS Newswire / November 20, 2025 / Medtronic, a global leader in healthcare technology, ...

Description: RBC Capital raised the firm’s price target on Medtronic (MDT) to $118 from $111 and keeps an Outperform rating on the shares. The company delivered a 1.0% beat on sales and 3.8% on EPS in Q2, driven by accelerating cardiovascular performance, the analyst tells investors in a research note. RBC further cites Medtronic expecting similar growth in Q3 and to exit the FY at 6%, noting that its thesis of growth acceleration is playing out. Published first on TheFly – the ultimate source for real-time,

Description: The diabetes care devices market is driven by rising diabetes cases and demand for advanced monitoring and insulin solutions. Opportunities lie in emerging markets where lifestyle shifts increase diabetes rates, along with innovations like AI analytics and connected devices accelerating personalized care.Dublin, Nov. 20, 2025 (GLOBE NEWSWIRE) -- The "Diabetes Care Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and For

Description: Medtronic shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 67 to 82.

Description: DoorDash, Baidu upgraded: Wall Street's top analyst calls

Description: Companies in The News Are: MDT,MGIC,AS,ESLT

Description: Pre-Market Stock Futures: Futures are trading higher this morning, as all the major indices once again closed lower on Tuesday, marking the fourth straight day of losses. The Dow Jones Industrials closed down 1.07% at 46,091, while the S&P 500 was last seen at 6617, down 0.83%. The NASDAQ, which has been hit the hardest ... Here Are Wednesday’s Top Wall Street Analyst Research Calls: DoorDash, Freeport-McMoRan, GitLab, Home Depot, Medtronic, Molson-Coors, and More

Description: Intuitive Surgical's Ion platform represents robust growth potential with strong procedure growth. Clinical trial data demonstrate superiority in diagnostic yield.

Description: Medtronic achieved global revenue of almost $9bn in Q2 FY26, with its cardiovascular portfolio contributing $3.44bn.

Description: Boston Scientific rides on strong neuromodulation momentum as sales climb, new technologies gain traction and recent acquisitions expand its pain-treatment reach.

Description: December Nasdaq 100 E-Mini futures (NQZ25) are trending up +0.44% this morning, signaling a modest rebound from a bruising stretch of losses, while investors look ahead to an earnings report from AI darling Nvidia.

Description: ↘️ Home Depot (HD): The big-box retailer cut its annual outlook as the home-improvement downturn continues. The stock closed down more than 6%, its biggest daily decline since 2023. Shares were up slightly after hours.

Description: Nvidia and Microsoft unveil a massive AI partnership with Anthropic, Home Depot reduces its full-year sales outlook, and Cloudflare reports widespread outages.

Description: Wall Street's major equity benchmarks on Tuesday slumped to their lowest levels since October as maj

Description: US equity indexes closed lower Tuesday as consumer discretionary and technology sectors slumped.

Description: A home improvement retailer faced pressure on Tuesday, Nov. 18, 2025, as housing market headwinds weighed on earnings, while a medical device maker benefitted from strong demand.

Description: Medtronic stock jumped and broke out Tuesday on a "clean beat" driven mainly by its pulsed field ablation technology.

Description: Health care stocks rose late Tuesday afternoon, with the NYSE Health Care Index up 0.3% and the Heal

Description: US benchmark equity indexes were lower intraday, weighed down by technology giants Microsoft (MSFT)

Description: Medtronic PLC (MDT) surpasses expectations with robust growth in cardiac ablation and raises full-year guidance, despite challenges in the cryo business and tariffs.

Description: US equity indexes declined in midday trading on Tuesday, but were off their respective session lows.

Description: Julie Hyman kicks off Yahoo Finance's Market Minute, taking a look at three of the trending stories on Wall Street, including Alphabet's (GOOG, GOOGL) new Gemini 3 AI model, Klarna's (KLAR) first earnings release since going public, and Medtronic's (MDT) earnings beat. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.

Description: Major U.S. equities indexes extended their slide Tuesday afternoon, amid worries about an AI bubble.

Description: Medtronic shares took off after the company posted better financial results than expected, boosted by what management called a “robust” volume of medical procedures. Medtronic sells surgical tools, plus medical devices that treat heart conditions, diabetes, and a range of other conditions, so it benefits when hospitals do more medical procedures. Investors have closely tracked volumes at Medtronic and its peers since the pandemic, which led to delays in many nonessential surgeries.

Description: Medtronic (MDT) raised its full-year outlook on Tuesday as the medical device maker logged stronger-

Description: MDT posts Q2 earnings and revenue beat, powered by strong Cardiovascular growth and a raised 2026 outlook that lifts its shares.

Description: The headline numbers for Medtronic (MDT) give insight into how the company performed in the quarter ended October 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Description: US equity futures were down ahead of Tuesday's opening bell as traders turned their focus to Nvidia'

Description: October brings 'tentative reprieve' to price corrections

Description: Medtronic (MDT) delivered earnings and revenue surprises of +3.82% and +1.11%, respectively, for the quarter ended October 2025. Do the numbers hold clues to what lies ahead for the stock?

Description: Medtronic raised its fiscal-year outlook after logging higher profit and sales in its latest quarter, boosted by robust demand across end markets and healthy procedure volumes.

Description: Market Domination Overtime host Josh Lipton previews several of the biggest stories to come tomorrow, Tuesday, November 18, including quarterly earnings results from companies like Home Depot (HD), Baidu (BIDU, 9888.HK), and Klarna (KLAR); the latest Homebuilder Confidence Index reading; and commentary from Federal Reserve governor Michael Barr. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime.

Description: New analyst reports spotlight Oracle's cloud momentum, strategic partnerships and expected fiscal 2026 sales growth.

Description: Consider buying Medtronic for its dividend and Pfizer for its turnaround potential if you are looking for attractive healthcare investments in November.

Description: It’s a big week for earnings this week with Nvidia and some key retail names taking center stage. This week we have Nvidia, Home Depot, Walmart, Target, Lowes, Palo Alto Networks, Medtronic and Pdd Holdings all reporting.

Description: Top market opportunities in the IoMT sector include the rapid growth of wearable devices, real-time monitoring, and the patient end-user segment. Fastest growth is expected in the Asia Pacific and South America regions. Companies should focus on non-invasive monitoring solutions, strategic partnerships, and educating end-users to capitalize on these trends. Global Internet Of Medical Things (IoMT) Market Global Internet Of Medical Things (IoMT) Market Dublin, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Th

Description: Investors can look forward to the restart of official economic data, starting with the September jobs report. A heavy dose of earnings is on the way too, including results from Nvidia, Home Depot and Walmart.

Description: Stocks face potentially a volatile week. Not just from the earnings that are due from the likes of Nvidia, Walmart, Home Depot, Lowe's and Target. There's also a bit of unease settling over markets coming from crypto land, where prices for bitcoin, ethereum and other crypto currencies have slumped ...

Description: The final full week of trading in November will bring investors key results from the biggest AI and retail names in the market.

Description: I'm a big fan of reliable dividend payers, and a few of the most reliable ones are attractively priced right now.

Description: Market Domination Overtime host Myles Udland previews several of the biggest stories to come throughout next week, including quarterly earnings results from major companies like Nvidia (NVDA), Home Depot (HD), Target (TGT), and Walmart (WMT); the latest round of commentary from top Federal Reserve officials alongside the minutes from the central bank's October FOMC meeting; and the release of the long-awaited September jobs report scheduled for Thursday, November 20. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime.

Description: With the government shutdown over, investors can look forward to the restart of jobs and inflation data, starting with the September jobs report. In the meantime, a heavy dose of earnings are on the way, including results from AI giant Nvidia and retailers Home Depot and Walmart.

Description: On November 12, 2025, Minze Health announced a three-year agreement with Medtronic to commercialize the Minze Diary Pod across the EMEA region for patients with overactive bladder symptoms using Medtronic’s InterStim system. This collaboration adds a digital health solution to Medtronic’s SNM therapy pathway, aiming to improve patient data collection and clinical decision-making in urinary care. We’ll examine how integrating an automated bladder diary could influence Medtronic’s positioning...

Description: The Oncology Institute (TOI) delivered earnings and revenue surprises of -16.67% and +11.71%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Description: Beyond analysts' top-and-bottom-line estimates for Medtronic (MDT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended October 2025.

Description: OnPoint Surgical, Inc., a leader in Augmented Reality (AR) and Artificial Intelligence (AI) guidance for spinal interventions, today announced the appointment of Jeremy Laynor as Chief Commercial Officer (CCO).

Description: Medtronic's Q2 results may see a lift from solid Cardiovascular momentum and strong Diabetes segment growth.

Description: J&J's MedTech sales rose 5.6% in Q3, fueled by cardiovascular strength and strategic portfolio shifts toward high-growth markets.

Description: ANTWERP, Belgium, November 12, 2025--Minze Health partners with Medtronic to integrate its automated bladder diary, Minze Diary Pod, into Sacral Neuromodulation care for OAB patients.

Description: Medtronic (MDT) shares edged slightly higher this week, with the stock gaining about 0.5% in the last trading session. Investors seem to be keeping an eye on the company’s performance as broader healthcare trends unfold. See our latest analysis for Medtronic. Medtronic’s 15.5% share price return so far this year reflects cautious optimism around its progress, even as recent 30-day softness has tempered momentum. The company’s one-year total shareholder return of 8.4% highlights steady but...

Description: Medtronic has its own surgical robot and it is working to become a more profitable business.

Description: The Diabetic Foot Ulcer Treatment Market offers growth opportunities due to rising diabetes prevalence, demand for cost-effective, painless treatments, and increased focus on advanced wound care and telemedicine. The expanding elderly population and obesity rates further drive market demand, while digital health solutions enhance access and outcomes. Diabetic Foot Ulcer Treatment Market Diabetic Foot Ulcer Treatment Market Dublin, Nov. 11, 2025 (GLOBE NEWSWIRE) -- The "Diabetic Foot Ulcer Treatm

Description: The regenerative medicine market offers significant opportunities in personalized stem cell therapies, driven by rising cancer cases and demand for effective chronic disease treatments. Emerging economies show potential for growth, propelled by an increasing need for tissue engineering and organ transplantation solutions. Regenerative Medicine Market Regenerative Medicine Market Dublin, Nov. 11, 2025 (GLOBE NEWSWIRE) -- The "Regenerative Medicine Market - Global Industry Size, Share, Trends, Opp

Description: Together, we can make a positive impact on the environment through advocacy, education, and connection NORTHAMPTON, MA / ACCESS Newswire / November 11, 2025 / We're focused on building a more sustainable future. To help with this, a grassroots group ...

Description: The board of directors of TE Connectivity plc (NYSE: TEL), a world leader in connectors and sensors, has appointed Ken Washington to the board, effective November 17, 2025.

Description: Quanterix (QTRX) delivered earnings and revenue surprises of -56.52% and +4.18%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Description: Secured $147.6 million in proceeds and committed capital following completion of strategic transactions and concurrent public and private equity offerings, led by $71.6 million in committed capital from Medtronic and Ligand, as well as $30 million from TerumoInitiated patient enrollments in the Virtue Trial evaluating Virtue® Sirolimus AngioInfusion™ Balloon (“Virtue SAB”) trial versus commercially available paclitaxel-coated balloon Demonstrated partnership-driven business model execution with

Description: Medtronic stock has seen its price target updated, with key financial assumptions reflecting both the company’s stable outlook and a slightly higher perception of risk. Improving analyst sentiment has supported this shift, as optimism grows around Medtronic’s product pipeline and strategic priorities. However, some experts remain watchful of potential near-term volatility. Read on to discover how you can stay informed about these evolving perspectives and what they might mean for the stock’s...

Description: The Sports Medicine industry is projected to grow significantly, reaching US$ 12.32 Billion by 2033 from US$ 7.27 Billion in 2024, marking a CAGR of 6.04%. This growth is driven by increased sports participation, a focus on injury prevention, and advancements in sports medicine technology like minimally invasive surgical tools. Companies such as Temple Ortho Biologics are pioneering solutions for young athletes. Leading market players include Zimmer Biomet, Medtronic, and Stryker, emphasizing in

Description: Intuitive Surgical's shares soar over 28% in a month on da Vinci 5 momentum, but margin and valuation pressures suggest caution for new buyers.

Description: Medtronic (MDT) closed the most recent trading day at $92.2, moving +2.38% from the previous trading session.

Description: "Driven by Technological Advances and Expanding Clinical Applications, Patient Monitoring Devices Are Revolutionizing Healthcare Delivery Across Hospitals, Home Care, and Remote Settings"Boston, Nov. 07, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Patient Monitoring Devices: Global Markets” is projected to grow from $36.7 billion in 2025 to $55.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 8.7% during the forecast period of 2025 to 2030.

Description: Key Insights The projected fair value for Medtronic is US$99.25 based on 2 Stage Free Cash Flow to Equity Current share...

Description: The workforce reduction is part of a restructuring designed to improve accountability and accelerate growth and innovation.

Description: Technological advancements, such as AI integration, enhance diagnostics and patient compliance, are propelling market expansion. Despite challenges like high screening costs and limited reimbursement policies, increasing awareness of early detection supports market growth. Colon Screening Market Colon Screening Market Dublin, Nov. 06, 2025 (GLOBE NEWSWIRE) -- The "Colon Screening Market Size and Growth Trends and Forecast Report 2025-2033" has been added to ResearchAndMarkets.com's offering.The

Description: The cardiovascular repair and reconstruction devices market offers vast opportunities with advancements in minimally invasive techniques, bioengineered materials, and personalized, patient-centered approaches. Growth is fueled by innovations in heart valve technology, rising healthcare expenditure, and an aging population seeking advanced treatment options. Cardiovascular Repair and Reconstruction Devices Market Cardiovascular Repair and Reconstruction Devices Market Dublin, Nov. 06, 2025 (GLOBE

Description: Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, November 18, 2025, for its second quarter of fiscal year 2026, which ended on Friday, October 24, 2025.

Description: Curaleaf Holdings, Inc. (CURLF) delivered earnings and revenue surprises of +14.29% and +1.04%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Description: BSX's Q3 EP sales soar 63% on FARAPULSE momentum, FDA label expansion and rising global adoption.

Description: The general manager for the business says building a market is something the medtech giant knows how to do.

Description: The global disposable medical device market is set to expand from USD 113.95 billion in 2025 to USD 144.85 billion by 2030, driven by a 4.9% CAGR. Factors such as heightened concern over hospital-acquired infections (HAIs), increased surgical procedures, and demand for cost-effective, single-use solutions propel growth. The drug delivery devices segment is leading in growth due to rising chronic disease cases and vaccine programs. The plastic-based segment is growing due to cost-effectiveness an

Description: Despite underperforming the market over the past year, Medtronic still enjoys fairly upbeat outlook from analysts.

Description: Healthcare has been an extraordinarily resilient industry to put cash to work in through the years.

Description: Cardiac mapper turned treatment of his own heart condition into a new career NORTHAMPTON, MA / ACCESS Newswire / November 3, 2025 / David Stalls thought the dangerous heart rhythm problem that plagued his health was a curse-until he turned treating ...

Description: NEW HOPE, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with market-leading global medical device companies, today announced that company management will host a business update call on Wednesday, November 12th at 8:00 AM ET. The business update will focus on recent significant clinical, strategic and financing develop

Description: The US neurology devices market is driven by rising neurological disorders and tech advancements, supported by government R&D funding. Key segments include neurostimulation and neurosurgery devices, with major players like Medtronic and Boston Scientific. Opportunities lie in innovation and strategic collaborations. U.S. Neurology Devices Market U.S. Neurology Devices Market Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "United States Neurology Devices Market Size, Share, Growth, Trends, Opportu

Description: With its stock down 4.5% over the past month, it is easy to disregard Medtronic (NYSE:MDT). To decide if this trend...

Description: The AI rally has many investors wondering where to turn in anticipation of its end. The medical-device maker is one solid option.

Description: In the most recent trading session, Medtronic (MDT) closed at $91.73, indicating a -1.61% shift from the previous trading day.

Description: NORTHAMPTON, MA / ACCESS Newswire / October 29, 2025 / Medtronic Decision means millions of Americans have access to the Medtronic Symplicity Spyral™ renal denervation system Edwin Jimenez knows a thing or two about staying physically fit. "I grew ...

Description: National Medicare coverage paves the way for a larger patient population to access the blood pressure treatment, which gained FDA approval in 2023.

Description: Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that the Centers for Medicare & Medicaid Services (CMS) has released the final National Coverage Determination (NCD) on renal denervation, applicable to the Symplicity Spyral™ renal denervation (RDN) system, also known as the Symplicity blood pressure procedure. This final determination will now provide Medicare patients with access to the Symplicity blood pressure procedure for the treatment of uncontrolled hyp

Description: The United States Insulin Pump Market is projected to grow from US$ 1.55 billion in 2024 to US$ 2.58 billion in 2033, with a CAGR of 5.84% from 2025-2033. This growth is driven by the rising diabetes prevalence, technological innovations in insulin delivery, and increased awareness of continuous glucose monitoring and personalized diabetes care. Key players like Medtronic, Insulet, and Tandem Diabetes Care are leading the market with smart insulin pumps integrated with CGMs for automated and rem

Description: Patients treated with Symplicity Spyral had significantly lower blood pressure than people who received a sham treatment after three years.

Description: Medtronic is expected to release its second-quarter results next month, and analysts project a single-digit earnings increase.

Description: The long-awaited face-off between these two medical device giants is finally upon us.

Description: The cardiovascular repair market is fueled by an aging population, technological advancements, and the rise in comorbidities. Opportunities lie in innovative, minimally invasive devices, value-based contracting, and regional market dynamics. Emphasizing personalized, data-driven solutions and supply chain resilience is crucial for growth. Cardiovascular Repair & Reconstruction Devices Market Cardiovascular Repair & Reconstruction Devices Market Dublin, Oct. 27, 2025 (GLOBE NEWSWIRE) -- The "Card

Description: These two healthcare giants are doing what they need to do to get their businesses rocking and rolling again.

Description: Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced new, long-term results from its final report of the SPYRAL HTN-ON MED randomized clinical trial, showing that patients treated with the Symplicity™ Spyral renal denervation (RDN) procedure experienced significantly greater reductions in blood pressure compared to sham patients through three years. The data were presented as part of Featured Clinical Research during the 2025 Transcatheter Cardiovascular Therapeut

Description: One is an out-of-favor dividend stock that's working to return to growth, and one just scored a big win.

Description: Looking at high-yield healthcare stocks? These three stand out (but one has a slight skew to its story).

Description: Medtronic’s stock narrative has recently shifted, as reflected in a modest rise in the consensus analyst price target from $99.90 to $101.13. This adjustment follows updated models from analysts who have responded to increasing investor optimism and anticipation surrounding key product launches. Stay tuned to discover how investors and observers can keep pace with these ongoing updates to Medtronic’s evolving outlook. What Wall Street Has Been Saying Analyst sentiment toward Medtronic has...

Description: In the closing of the recent trading day, Medtronic (MDT) stood at $94.21, denoting a -1.76% move from the preceding trading day.

Description: The GCC catheter market is projected to grow from USD 579.83 million in 2024 to USD 1.28 billion by 2033, with a CAGR of 9.21% from 2025 to 2033. This growth is driven by an increase in chronic diseases, surgical procedures, and advanced healthcare infrastructure across GCC countries. The demand for minimally invasive treatments and the aging population further bolster market expansion. Key sectors such as cardiovascular, microcatheters, and intermittent catheters are witnessing significant grow

Description: The medical-device giant is positioning its Hugo RAS system to compete with Intuitive Surgical's da Vinci systems.

Description: Solventum (NYSE: SOLV) announced today the appointment of Heather Knight as Chief Commercial Officer, effective November 10, 2025. In this newly created role, Ms. Knight will oversee global commercial and R&D operations across Solventum's MedSurg, Dental Solutions and Health Information Systems segments, and will report directly to CEO Bryan Hanson.

Description: CALGARY, Alberta, Oct. 21, 2025 (GLOBE NEWSWIRE) -- A growing number of companies are using Giftbit, a simple but powerful digital rewards platform, to achieve remarkable results. Gift cards and prepaid cards, sent instantly and at scale, are effective in countless business scenarios. Three companies to watch, MustardHub, Medtronic, and Natural Factors, are seeing success with simplified incentive programs that increase engagement, and deliver consistent experiences across the globe. Customer Sp

Description: Dublin, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The "Medtronic PLC (MDT) - Product Pipeline Analysis, 2025 Update" has been added to ResearchAndMarkets.com's offering. This detailed report serves as a valuable source of data, analysis, and actionable insights into Medtronic's portfolio of pipeline products. It provides essential information about the company, its key products, and esteemed brands, enhancing decision-making capabilities and assisting in creating effective counter strategies to secure a

Description: MINNEAPOLIS, MN / ACCESS Newswire / October 21, 2025 / MD&M Midwest, the region's largest annual end-to-end design and manufacturing event taking place on October 21-22 at the Minneapolis Convention Center announces keynote speakers for the event's ...

Description: Key opportunities in the global patient monitoring devices market include expanding use of miniaturized multi-sensing devices and adoption due to stringent regulations, enhanced self-management of chronic diseases, and growth potential in emerging regions. Sustainability and ESG practices also offer competitive advantages. Patient Monitoring Devices Market Patient Monitoring Devices Market Dublin, Oct. 20, 2025 (GLOBE NEWSWIRE) -- The "Patient Monitoring Devices: Global Markets" report has been

Description: Abbott posts strong Q3 growth across key segments, but tariff pressures and weak Diagnostics weigh on near-term momentum.